Covid Vaccination and IBD Medications

Posted Thursday August 19, 2021

People with chronic inflammatory conditions that take medication can have a somewhat reduced response to vaccines. These people still get an immune response to vaccines that is protective and useful to them, and also to the community.

 With COVID-19, the current recommendation is for people with IBD, including those on all types of medication, to get the first and second vaccine when advised. It is not recommended to time the dose of infusions or tablets against vaccine timing, as current evidence is that this won’t make a big difference. What is clear is vaccinating as many people in Aotearoa New Zealand as quickly as possible will reduce the burden and severity of current and future outbreaks, including with more concerning COVID-19 variants such as Delta.

We are watching for updates about antibody testing and how this reflects protection and immunity, optimal timing of the second vaccine, and if a third or ‘booster’ vaccine could help.

In the meanwhile, please encourage your patients to get their shots, and please keep an eye on the Ministry of Health guidelines.

Ngā mihi nui


President NZSG

Dr Richard E. Stein, MD, FRACP, FACG, AGAF

Chairman, Crohn’s & Colitis NZ Charitable Trust


Related Articles

2025 Advanced Gastroenterology Training Opportunities (Match 2024) Information

Tuesday April 2, 2024

NZSG will be accepting applications for placements from the 8th of April 2024. The final date for applying is Friday the...

Vacancies Events + 2 More

Read more »

NZCCRTGE - Conjoint Committee News

Friday March 15, 2024

The NZCCRTGE has made a few changes we'd like to let you know about


Read more »

Supply Issue Notice from Pharmac

Thursday February 15, 2024

We've received news about long-term supply issue affecting the Dipentum brand of olsalazine (250 mg capsules and 500 mg ...

News Pharma News

Read more »